Calcium channel blockers (CCBs) are antihypertensive drugs that lower blood pressure by blocking calcium entry into heart and blood vessel cells, leading to relaxation of vascular smooth muscle. They are classified into three groups: phenylalkylamines, benzothiazepines, and dihydropyridines, with drugs like nifedipine and amlodipine for specific uses such as angina. The document covers their mechanism of action, structural activity relationships of 1,4-dihydropyridine, and physical properties of various CCBs.